DerickHon ManLauMD

Oncology • Sacramento, CA

Director of New Hope Cancer Center, Beijing, China

Join to view full profile

Dr. Lau is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Lau's full profile

Already have an account?

Office
4501 X St
Sacramento, CA 95817
Phone+1 916-734-3772

Fax+1 916-734-7946

Education & Training

University of California Davis HealthFellowship, Hematology and Medical Oncology, 1990 - 1991
Stanford Health Care-Sponsored Stanford UniversityResidency, Pathology-Anatomic and Clinical, 1987 - 1989
University of California (San Francisco)/FresnoResidency, Internal Medicine, 1984 - 1987
University of Missouri-Columbia School of MedicineClass of 1984

Certifications & Licensure

CA State Medical License 1985 - 2026
American Board of Internal Medicine Internal Medicine

Clinical Trials

S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III Non-small Cell Lung Cancer Start of enrollment: 1998 Feb 01
Completed
Phase 2
Chemotherapy, Tirapazamine, and Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer Start of enrollment: 2002 Mar 01
Completed
Phase 1
S0526: Pemetrexed Disodium in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2006 Jul 01
Terminated
Phase 2
S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer Start of enrollment: 2006 Apr 01
Terminated
Phase 1
Irinotecan and Carboplatin in Treating Patients With Metastatic or Recurrent Small Cell Lung Cancer Start of enrollment: 2001 Oct 01
Completed
Phase 2
S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma Start of enrollment: 2007 Jul 01
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

12 citations
Phase I study of the halichondrin B analogue eribulin mesylate in combination with cisplatin in advanced solid tumors
Marianna Koczywas, Paul Frankel, Timothy W. Synold, Heinz-Josef Lenz, Joanne E. Mortimer
British Journal of Cancer. 2014-12-09
56 citations
Quality of life among long-term survivors of head and neck cancer treated by intensity-modulated radiotherapy.
Allen M. Chen, Megan E. Daly, D. Gregory Farwell, Esther Vazquez, Jean Courquin
JAMA Otolaryngology-- Head & Neck Surgery. 2014-02-01
41 citations
Feasibility and toxicity of concurrent chemoradiation for elderly patients with head and neck cancer
Megan E. Daly, Derick H Lau, D. Gregory Farwell, Quang Luu, Paul J. Donald
American Journal of Otolaryngology. 2013-11-01